CRCGN014_HEPG2_24H:L11 Gene Set
Genes
28 genes differentially expressed following the CRCGN014_HEPG2_24H:L11 small molecule perturbation from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
increased expression
| Symbol |
Name |
Standardized Value |
|
GPER1
|
G protein-coupled estrogen receptor 1
|
5.204
|
|
MOK
|
MOK protein kinase
|
4.60454
|
|
CBR3
|
carbonyl reductase 3
|
4.46796
|
|
MLLT11
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11
|
4.35914
|
|
ABCC5
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 5
|
4.35886
|
|
HERC6
|
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6
|
4.25005
|
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa
|
4.05185
|
|
BAD
|
BCL2-associated agonist of cell death
|
3.73914
|
|
TBPL1
|
TBP-like 1
|
3.4542
|
|
SQOR
|
sulfide quinone oxidoreductase
|
3.42846
|
|
ABHD6
|
abhydrolase domain containing 6
|
3.22639
|
|
CEBPZ
|
CCAAT/enhancer binding protein (C/EBP), zeta
|
2.99251
|
|
CDPF1
|
cysteine-rich, DPF motif domain containing 1
|
2.97689
|
|
LOC122526780
|
uncharacterized LOC122526780
|
2.95396
|
|
PRR15L
|
proline rich 15-like
|
2.21772
|
|
CCNF
|
cyclin F
|
2.184
|
|
STIMATE
|
STIM activating enhancer
|
2.04348
|
decreased expression
| Symbol |
Name |
Standardized Value |
|
FGFR4
|
fibroblast growth factor receptor 4
|
-6.61738
|
|
LDHD
|
lactate dehydrogenase D
|
-5.287
|
|
ST6GALNAC2
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2
|
-4.69211
|
|
CHMP4B
|
charged multivesicular body protein 4B
|
-4.37489
|
|
FAIM
|
Fas apoptotic inhibitory molecule
|
-4.21998
|
|
CCNB2
|
cyclin B2
|
-3.7421
|
|
DERA
|
deoxyribose-phosphate aldolase (putative)
|
-3.60871
|
|
RNF167
|
ring finger protein 167
|
-3.17145
|
|
TLR4
|
toll-like receptor 4
|
-2.78336
|
|
PKIG
|
protein kinase (cAMP-dependent, catalytic) inhibitor gamma
|
-2.68899
|
|
GNAS
|
GNAS complex locus
|
-2.2312
|
